Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
US Army
Cantor Fitzgerald
Mallinckrodt
Dow
Farmers Insurance
Novartis
McKesson
Queensland Health
Boehringer Ingelheim

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,413,141

« Back to Dashboard

Summary for Patent: 4,413,141
Title: 2-(Difluoromethyl)-2,5-diaminopentanoic acid
Abstract:This invention relates to 2-(difluoromethyl)-2,5-diaminopentanoic acid, or a pharmaceutically acceptable acid addition salt thereof, and to the methods for the preparation and use thereof.
Inventor(s): Bey; Philippe (Strasbourg, FR), Jung; Michel (Illkirch-Graffenstaden, FR)
Assignee: Merrell Toraude et Compagnie (Strasbourg, FR)
Application Number:06/419,347
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 4,413,141

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,413,141

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 3732778 ➤ Subscribe
Australia 522660 ➤ Subscribe
Belgium 868882 ➤ Subscribe
Belgium 881208 ➤ Subscribe
Belgium 881209 ➤ Subscribe
Belgium 881210 ➤ Subscribe
Canada 1091661 ➤ Subscribe
Switzerland 642055 ➤ Subscribe
Germany 2828739 ➤ Subscribe
Denmark 148322 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Teva
Cantor Fitzgerald
Dow
Baxter
Johnson and Johnson
Chinese Patent Office
Fuji
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot